Mortality Risk According to Different Clinical Characteristics of First Episode of Liver Decompensation in Cirrhotic Patients: A Nationwide, Prospective, 3-Year Follow-Up Study in Italy

医学 腹水 失代偿 肝硬化 内科学 肝性脑病 前瞻性队列研究 肝移植 胃肠病学 入射(几何) 危险系数 比例危险模型 门脉高压 外科 移植 置信区间 物理 光学
作者
Savino Bruno,Simone Saibeni,Vincenzo Bagnardi,C. Vandelli,Massimo De Luca,Martina Felder,Anna Ludovica Fracanzani,C. Prisco,G. Vitaliani,L. Simone,Giovanni Battista Gaeta,Maria Stanzione,Marcello Persico,Caterina Furlan,Tommaso Stroffolini,Francesco Salerno,Patrick Maisonneuve,Piero Luigi Almasio
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:108 (7): 1112-1122 被引量:40
标识
DOI:10.1038/ajg.2013.110
摘要

The occurrence of decompensation marks a crucial turning point in the course of cirrhosis. The purpose of this study was to assess the risk of mortality according to the clinical characteristics of first decompensation, considering also the impact of acute-on-chronic liver failure (AoCLF).We conducted a prospective nationwide inception cohort study in Italy. Decompensation was defined by the presence of ascites, either overt or detected by ultrasonography (UD), gastroesophageal variceal bleeding (GEVB), and hepatic encephalopathy (HE). AoCLF was defined according to the Asian Pacific Association for the Study of the Liver criteria. Multivariable Cox proportional hazards regression was used to analyze the risk of failure (death or orthotopic liver transplantation (OLT)).A total of 490 consecutive cirrhotic patients (314 males, mean age 60.9±12.6 years) fulfilled the study criteria. AoCLF was identified in 59 patients (12.0%). Among the remaining 431 patients, ascites were found in 330 patients (76.6%): in 257 (77.8%) as overt ascites and in 73 (22.2%) as UD ascites. GEVB was observed in 77 patients (17.9%) and HE in 30 patients (7.0%). After a median follow-up of 33 months, 24 patients underwent OLT and 125 died. The cumulative incidence of failure (death or OLT) after 1, 2, and 3 years was, respectively, 28, 53, and 62% in patients with AoCLF; 10, 18, and 25% in patients with UD ascites; 17, 31, and 41% in patients with overt ascites; and 8, 12, and 24% in patients with GEVB (P<0.0001).AoCLF is responsible for a relevant proportion of first decompensation in cirrhotic patients and is associated with the poorest outcome. Patients with UD ascites do not have a negligible mortality rate and require clinical monitoring similar to that of patients with overt ascites.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小李给我支棱起来完成签到,获得积分10
1秒前
David完成签到 ,获得积分10
2秒前
浅沫juanjuan完成签到 ,获得积分10
2秒前
长安完成签到,获得积分10
2秒前
rice0601完成签到,获得积分10
2秒前
粥可温完成签到,获得积分10
2秒前
K_GRAPES完成签到,获得积分10
3秒前
阿坤完成签到,获得积分10
3秒前
5秒前
沙力VAN完成签到,获得积分10
5秒前
kong发布了新的文献求助10
5秒前
728完成签到,获得积分10
5秒前
5秒前
Sera完成签到,获得积分10
6秒前
小城故事和冰雨完成签到,获得积分10
6秒前
ASXC给ASXC的求助进行了留言
6秒前
ld2024完成签到,获得积分10
8秒前
健壮的涑完成签到 ,获得积分10
8秒前
杨晓白完成签到,获得积分10
8秒前
10秒前
金刚大王完成签到,获得积分10
10秒前
Xl完成签到,获得积分10
11秒前
11秒前
想跟这个世界讲个道理完成签到,获得积分10
12秒前
铜离子发布了新的文献求助10
12秒前
CodeCraft应助黄启烽采纳,获得10
12秒前
13秒前
清嘉完成签到,获得积分10
13秒前
yn完成签到,获得积分10
14秒前
儒雅南风完成签到 ,获得积分10
14秒前
结实的栾完成签到,获得积分10
14秒前
无为完成签到 ,获得积分10
15秒前
做实验太菜完成签到,获得积分10
15秒前
专注鸡完成签到,获得积分10
15秒前
甜甜的铭完成签到,获得积分10
15秒前
yuanyuan完成签到,获得积分10
15秒前
Bit完成签到,获得积分10
16秒前
领导范儿应助啦啦啦采纳,获得10
16秒前
yan完成签到,获得积分10
17秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A new approach to the extrapolation of accelerated life test data 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3953555
求助须知:如何正确求助?哪些是违规求助? 3499137
关于积分的说明 11094114
捐赠科研通 3229679
什么是DOI,文献DOI怎么找? 1785728
邀请新用户注册赠送积分活动 869490
科研通“疑难数据库(出版商)”最低求助积分说明 801478